Uptake of In-111 pentetreotide by pleural plaques.
(1998) Clinical Nuclear Medicine — Vol. 23, n° 5, p. 298-301 (1998)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- Somatostatin receptor imaging with In-111 pentetreotide has been validated for the diagnosis and staging of chest tumors with neuroendocrine differentiation such as bronchial carcinoid and small cell lung cancer. In-111 pentetreotide uptake is not specific for neuroendocrine tumors because somatostatin receptors are also expressed by white blood cells, leading to the in vivo visualization sites of infection sites or active inflammation. Pleural plaques may be due to asbestos exposure or tuberculosis. Presented here are three cases of In-111 pentetreotide uptake in pleural plaques. This uptake by benign lesions may be misleading in the diagnostic work-up of patients with lung tumors.
- Affiliations
Citations
Lonneux, M., Pieters, T., Jamar, F., Leners, N., & Pauwels, S. (1998). Uptake of In-111 pentetreotide by pleural plaques. Clinical Nuclear Medicine, 23(5), 298-301. https://doi.org/10.1097/00003072-199805000-00006 (Original work published 1998)